Decrease in clinical hypoglycemia in young children with type 1 diabetes treated with free-mixed aspart and detemir insulin: an open labeled randomized trial
- PMID: 24888575
- DOI: 10.1111/pedi.12156
Decrease in clinical hypoglycemia in young children with type 1 diabetes treated with free-mixed aspart and detemir insulin: an open labeled randomized trial
Erratum in
-
Corrigendum.Pediatr Diabetes. 2016 Mar;17(2):164. doi: 10.1111/pedi.12365. Pediatr Diabetes. 2016. PMID: 26833723 No abstract available.
-
Corrigendum.Pediatr Diabetes. 2017 Mar;18(2):163. doi: 10.1111/pedi.12511. Pediatr Diabetes. 2017. PMID: 28145635 No abstract available.
Abstract
Objective: To compare the effectiveness of a free-mix of aspart (A) and detemir (D) insulins (ADIM) with a commonly used premixed fixed-ratio aspart and neutral protamine Hagedorn (NPH) insulin mixture (ANIM) in young children with type 1 diabetes (T1D) treated with twice-daily injections. The trial thus compares not only D vs. NPH, but also flexible, personalized insulin preparations vs. a fixed premixed preparation.
Research design and methods: This single-center, open-label, randomized trial included 82 children with T1D. Patients stayed on ANIM for 1 yr of optimization of disease management, then were randomized to either ANIM (N = 41) or ADIM (N = 41) for another year.
Outcomes: Frequency of severe or symptomatic episodes, glycated hemoglobin A1c (HbA1c), and blood glucose (BG) values.
Results: Compared with ANIM, ADIM decreases symptomatic hypoglycemia by approximately 2 fold (p < 0.001) and severe hypoglycemia by 7-10 fold (p = 0.04). ADIM somewhat reduced BG variation. Mean HbA1c was comparable on ADIM (7.9 ± 0.8 %; 63 ± 9 mmol/mol) and ANIM (8.2 ± 0.7 %; 66 ± 8 mmol/mol).
Conclusions: Using a free-mixing preparation of aspart and detemir insulin decreases hypoglycemia in young children with type 1 diabetes.
Keywords: aspart-detemir mixture; diabetes children; hypoglycemia; type 1 diabetes.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
-
Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart.Diabetes Care. 2003 Mar;26(3):590-6. doi: 10.2337/diacare.26.3.590. Diabetes Care. 2003. PMID: 12610006 Clinical Trial.
-
Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes.Diabetologia. 2004 Apr;47(4):622-9. doi: 10.1007/s00125-004-1365-z. Diabetologia. 2004. PMID: 15298338 Clinical Trial.
-
Effect of insulin analogues on frequency of non-severe hypoglycaemia in patients with type 1 diabetes prone to severe hypoglycaemia: The HypoAna trial.Diabetes Metab. 2016 Sep;42(4):249-55. doi: 10.1016/j.diabet.2016.03.001. Epub 2016 Apr 7. Diabetes Metab. 2016. PMID: 27068361 Clinical Trial.
-
(Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus.Cochrane Database Syst Rev. 2021 Mar 4;3(3):CD013498. doi: 10.1002/14651858.CD013498.pub2. Cochrane Database Syst Rev. 2021. PMID: 33662147 Free PMC article.
-
Treat-to-target trials: uses, interpretation and review of concepts.Diabetes Obes Metab. 2014 Mar;16(3):193-205. doi: 10.1111/dom.12129. Epub 2013 Jun 14. Diabetes Obes Metab. 2014. PMID: 23668598 Free PMC article. Review.
Cited by
-
Increasing secular trends in height and obesity in children with type 1 diabetes: JSGIT cohort.PLoS One. 2020 Nov 23;15(11):e0242259. doi: 10.1371/journal.pone.0242259. eCollection 2020. PLoS One. 2020. PMID: 33227006 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical